THALES
29.4.2021 10:02:07 CEST | Business Wire | Press release
To guarantee security and complete control of data, Thales and OVHcloud have joined forces to offer Citadel Team encrypted messaging customers a trusted hosting platform that guarantees the sovereignty of their data. Citadel Team customers' data is encrypted and stored at OVHcloud, via its own datacenters located in France.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210429005027/en/
Cybercriminals are taking advantage of the Covid-19 pandemic to infiltrate enterprise networks through vulnerabilities created by the large numbers of people working from home. With the sharp rise in cyberattacks — there have been four times the number of attacks in 2020 than in 2019 according to ANSSI , France’s national agency for information system security. There has also been a growing demand for greater security on data sharing and communication apps; it is more important than ever for companies and users to protect their information, encrypt their data and suitable hosting solution to control how it is stored.
Thales offers professionals a secure instant messaging service, Citadel Team, which requires users to register with a company email address. Already adopted by over a third of CAC 40 companies, the service includes the encryption system used by 50 NATO countries. It provides the guarantee that a company’s data will not be used or sold to third parties. It also ensures that all data is stored in France and that the organization can easily manage user devices themselves. Based on these guarantees, the Citadel development teams have recently obtained the France Cybersecurity 2021 label *.
Citadel Team’s new partner, OVHcloud, shares the same values ofsecurity, sovereignty and data protection. Hosting Citadel Team data in OVHcloud's data centers in France is a guarantee for customers of the application to benefit from an environment of trust. OVHcloud relies on an integrated model that gives it complete control over its value chain: from the design of its servers to the construction and management of its data centers, not forgetting the orchestration of its fiber optic network.
Available free of charge, Citadel Team offers users end-to-end encrypted messaging and voice services on a smartphone or computer, plus a host of premium services, including videoconferencing, group calls and screen sharing. Citadel Team continues to add new functionality tailored to the communication requirements of professionals to offer an all-in-one communication solution without sacrificing data security or usability. Citadel Team is also a member of the Open Trusted Cloud programme, initiated by OVHcloud to federate an ecosystem of trusted players and solutions that respect data protection laws.
“We are especially proud to announce this partnership to our customers and the general public. Thales and OVH have been trusted partners for many years, and by combining our strengths under this new hosting arrangement, we are taking the sovereign Citadel Team solution to the next level to offer our customers the very best data hosting option available.” Pierre-Yves Jolivet, Vice President, Cyber Defence Solutions, Thales.
« We welcome Thales' choice to host Citadel Team data on OVHcloud infrastructures. The combination of our strengths is good news for users looking for guarantees that their data will be respected. They can now be sure to benefit from an alternative, trusted and secure end-to-end solution.» Caroline Comet-Fraigneau, VP France and Benelux, OVHcloud
* The label «France Cybersecurity », is a guarantee for users that the products and services bearing the label are French and that they have clear and well-defined functionalities, with a level of quality attested by an independent jury.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
PLEASE VISIT
Thales Group
Defence and Security | Thales Group
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing14.9.2026 09:00:00 CEST | Press release
Thales launches Luna 8, a new hardware security module (HSM) to provide future-ready, quantum resistant security to protect critical data and applications Powered by a Thales designed cryptographic processor, it delivers unparalleled performance, enhanced protection and the flexibility to adapt to new security needs Drawing on decades of cryptographic expertise, Luna 8 combines trusted security with support for emerging technologies, including post quantum cryptography According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/ ©Thales To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, tod
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 09:00:00 CEST | Press release
Acceptance is based on pivotal Phase 3 data demonstrating rapid, durable and consistent skin clearance, including in high-impact sites, in a convenient once-daily pill Results from nearly 3,000 patients support potential for next-generation TYK2 inhibitor to redefine oral treatment expectations in psoriasis The Prescription Drug User Fee Act (PDUFA) target action date is in the first quarter of calendar year 2027 Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly
SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 09:00:00 CEST | Press release
The Memorandum of Understanding (MoU) and additional contract signal a new phase of collaboration on market development in the Asia Pacific (APAC) region SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter
Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 07:00:00 CEST | Press release
Extending Link-16 interoperability without platform-level hardware integration Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participant
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom